Does AMLODIPINE\TELMISARTAN Cause Mobility decreased? 55 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Mobility decreased have been filed in association with AMLODIPINE\TELMISARTAN. This represents 11.2% of all adverse event reports for AMLODIPINE\TELMISARTAN.
55
Reports of Mobility decreased with AMLODIPINE\TELMISARTAN
11.2%
of all AMLODIPINE\TELMISARTAN reports
0
Deaths
55
Hospitalizations
How Dangerous Is Mobility decreased From AMLODIPINE\TELMISARTAN?
Of the 55 reports, 55 (100.0%) required hospitalization, and 35 (63.6%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\TELMISARTAN. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE\TELMISARTAN Cause?
Hypotension (70)
Toxicity to various agents (66)
Balance disorder (60)
Depressed level of consciousness (60)
Pain (60)
Constipation (59)
Blood calcium decreased (57)
Fall (57)
Sedation complication (56)
Cognitive disorder (55)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AMLODIPINE\TELMISARTAN Alternatives Have Lower Mobility decreased Risk?
AMLODIPINE\TELMISARTAN vs AMLODIPINE\VALSARTAN
AMLODIPINE\TELMISARTAN vs AMMONIUM
AMLODIPINE\TELMISARTAN vs AMNESTEEM
AMLODIPINE\TELMISARTAN vs AMOXAPINE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN